Lipman J - Search Results

1

Initial antimicrobial management of sepsis.

Niederman MS, Baron RM, Bouadma L, Calandra T, Daneman N, DeWaele J, Kollef MH, Lipman J, Nair GB. Niederman MS, et al. Among authors: lipman j. Crit Care. 2021 Aug 26;25(1):307. doi: 10.1186/s13054-021-03736-w. Crit Care. 2021. PMID: 34446092 Free PMC article. Review.

2

Antibacterial dosing in intensive care: pharmacokinetics, degree of disease and pharmacodynamics of sepsis.

Roberts JA, Lipman J. Roberts JA, et al. Among authors: lipman j. Clin Pharmacokinet. 2006;45(8):755-73. doi: 10.2165/00003088-200645080-00001. Clin Pharmacokinet. 2006. PMID: 16884316 Review.

3

Pharmacokinetic issues for antibiotics in the critically ill patient.

Roberts JA, Lipman J. Roberts JA, et al. Among authors: lipman j. Crit Care Med. 2009 Mar;37(3):840-51; quiz 859. doi: 10.1097/CCM.0b013e3181961bff. Crit Care Med. 2009. PMID: 19237886 Review.

4

Piperacillin penetration into tissue of critically ill patients with sepsis--bolus versus continuous administration?

Roberts JA, Roberts MS, Robertson TA, Dalley AJ, Lipman J. Roberts JA, et al. Among authors: lipman j. Crit Care Med. 2009 Mar;37(3):926-33. doi: 10.1097/CCM.0b013e3181968e44. Crit Care Med. 2009. PMID: 19237898 Clinical Trial.

5

A systematic review on clinical benefits of continuous administration of beta-lactam antibiotics.

Roberts JA, Webb S, Paterson D, Ho KM, Lipman J. Roberts JA, et al. Among authors: lipman j. Crit Care Med. 2009 Jun;37(6):2071-8. doi: 10.1097/CCM.0b013e3181a0054d. Crit Care Med. 2009. PMID: 19384201 Review.

6

A new paradigm for treating infections: "go hard and go home".

Lipman J, Boots R. Lipman J, et al. Crit Care Resusc. 2009 Dec;11(4):276-81. Crit Care Resusc. 2009. PMID: 20001878 Review.

7

Antimicrobial pharmacokinetic and pharmacodynamic issues in the critically ill with severe sepsis and septic shock.

Varghese JM, Roberts JA, Lipman J. Varghese JM, et al. Among authors: lipman j. Crit Care Clin. 2011 Jan;27(1):19-34. doi: 10.1016/j.ccc.2010.09.006. Crit Care Clin. 2011. PMID: 21144984 Review.

8

Physiological changes in the critically ill patient with sepsis.

Hosein S, Udy AA, Lipman J. Hosein S, et al. Among authors: lipman j. Curr Pharm Biotechnol. 2011 Dec;12(12):1991-5. doi: 10.2174/138920111798808248. Curr Pharm Biotechnol. 2011. PMID: 21554219 Review.

9

What's behind the failure of emerging antibiotics in the critically ill? Understanding the impact of altered pharmacokinetics and augmented renal clearance.

Udy AA, Roberts JA, De Waele JJ, Paterson DL, Lipman J. Udy AA, et al. Among authors: lipman j. Int J Antimicrob Agents. 2012 Jun;39(6):455-7. doi: 10.1016/j.ijantimicag.2012.02.010. Epub 2012 Apr 6. Int J Antimicrob Agents. 2012. PMID: 22483562 No abstract available.

10

DALI: Defining Antibiotic Levels in Intensive care unit patients: a multi-centre point of prevalence study to determine whether contemporary antibiotic dosing for critically ill patients is therapeutic.

Roberts JA, De Waele JJ, Dimopoulos G, Koulenti D, Martin C, Montravers P, Rello J, Rhodes A, Starr T, Wallis SC, Lipman J. Roberts JA, et al. Among authors: lipman j. BMC Infect Dis. 2012 Jul 6;12:152. doi: 10.1186/1471-2334-12-152. BMC Infect Dis. 2012. PMID: 22768873 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

946 results

Search Page

Filters